SCHIPing Away at Sustainable Federal Spending

Health Policy Studies Director Michael F. Cannon on Senate consideration of the House-passed SCHIP expansion:

January 15, 2009 • News Releases

Media Contact: (202) 789‑5200

Expanding SCHIP is bad medicine for the intended beneficiaries and for taxpayers. SCHIP is a costly, poorly targeted, and unproven strategy for improving child health. In addition, SCHIP crowds out private health insurance, discourages families from climbing the economic ladder, and does nothing to address the systemic quality problems in America’s health care sector. But if your goal is to march all Americans into a government‐​run health care program, SCHIP is just what the doctor ordered.